Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0318 Transporter Info | ||||
Gene Name | SLC36A1 | ||||
Transporter Name | Proton-coupled amino acid transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Approved Drug |
|||||
Aminocaproic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Aminocaproic acid inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Artemisinin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Artemisinin inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Cycloserine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Cycloserine inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Gamma-hydroxybutyric acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Gamma-hydroxybutyric acid inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Glycine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Glycine inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
L-alanine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
L-alanine inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
L-proline |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
L-proline inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Tretinoin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tretinoin increases the expression of SLC36A1 | [4] | |||
Acetaminophen |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Acetaminophen increases the expression of SLC36A1 | [5] | |||
Valproic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Valproic Acid increases the expression of SLC36A1 | [6] | |||
Caffeine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Caffeine inhibits the activity of SLC36A1 | [7] | |||
Drug in Phase 2/3 Trial |
|||||
AM-80 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
AM-80 increases the expression of SLC36A1 | [3] | |||
Drug in Phase 3 Trial |
|||||
Creatine ALS-08 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Creatine ALS-08 inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Tramiprosate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tramiprosate inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Drug in Phase 2 Trial |
|||||
Gamma-aminobutyric acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Gamma-aminobutyric acid inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Procysteine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Procysteine inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Investigative Drug |
|||||
Isonipecotic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Isonipecotic acid inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
L-isoleucine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
L-isoleucine inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
L-leucine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
L-leucine inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
L-serine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
L-serine inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Piperidine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Piperidine inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Sarcosine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Sarcosine inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Taurine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Taurine inhibits the transportation of L-proline by SLC36A1 | [1] | |||
Affected Drug/Substrate |
L-proline | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Milchsaure |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Milchsaure inhibits the expression of SLC36A1 | [11] | |||
5-Hydroxy-L-tryptophan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
5-Hydroxy-L-tryptophan inhibits the activity of SLC36A1 | [14] | |||
Natural Product |
|||||
Thapsigargin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Thapsigargin inhibits the expression of SLC36A1 | [9] | |||
Tobacco Smoke Pollution |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Tobacco Smoke Pollution increases the expression of SLC36A1 | [13] | |||
Dietary Constituent |
|||||
Infant formula |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Infant formula inhibits the transportation of Vigabatrin by SLC36A1 | [2] | |||
Affected Drug/Substrate |
Vigabatrin | Modulation Type | Inhibition | ||
Cell System |
Human enterocyte-like 2 cell (Caco-2)-PAT1 | ||||
Carcinogen |
|||||
Sodium bichromate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Sodium bichromate inhibits the expression of SLC36A1 | [8] | |||
Benzo(a)pyrene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Benzo(a)pyrene increases the expression of SLC36A1 | [12] | |||
Pesticide/Insecticide |
|||||
Dicrotophos |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Dicrotophos increases the expression of SLC36A1 | [10] | |||
Herbicide |
|||||
Atrazine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation 1 |
Atrazine inhibits the expression of SLC36A1 | [9] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.